
Results
121
Stocks with a market cap under US$50M.
121 companies
CTCBIO
Market Cap: ₩71.0b
Provides various pharmaceutical products in South Korea and internationally.
A060590
₩3,040.00
7D
6.5%
1Y
-50.3%
CCME Global
Market Cap: ₹4.7b
Does not have significant operations.
514336
₹99.25
7D
-14.8%
1Y
232.8%
Synbio Tech
Market Cap: NT$1.6b
Manufactures and sells human healthcare products and probiotics for animals.
1295
NT$46.85
7D
-0.2%
1Y
-58.7%
Ildong Holdings
Market Cap: ₩69.6b
Develops, manufactures, and supplies pharmaceutical products in South Korea and internationally.
A000230
₩6,320.00
7D
5.9%
1Y
-25.2%
aTyr Pharma
Market Cap: US$48.2m
A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.
ATYR
US$0.49
7D
-0.4%
1Y
-90.6%
TScan Therapeutics
Market Cap: US$47.3m
A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.
TCRX
US$0.72
7D
-6.5%
1Y
-58.7%
BIO-FD&CLtd
Market Cap: ₩67.3b
Develops active ingredients for anti-aging cosmetics in South Korea.
A251120
₩8,060.00
7D
10.3%
1Y
-56.4%
Norda
Market Cap: NOK 443.4m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 86.40
7D
0%
1Y
7.9%
Kidswell Bio
Market Cap: JP¥7.2b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥144.00
7D
2.9%
1Y
-46.9%
Cantargia
Market Cap: SEK 439.5m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 1.77
7D
-5.4%
1Y
-44.0%
Austar Lifesciences
Market Cap: HK$358.8m
An investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
6118
HK$0.70
7D
0%
1Y
-51.0%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$356.6m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.29
7D
-3.3%
1Y
-4.9%
Vext Science
Market Cap: CA$63.2m
Through its subsidiaries, engages in integrated cannabis operations in the United States.
VEXT
CA$0.26
7D
10.9%
1Y
6.3%
Sinsin Pharmaceutical
Market Cap: ₩64.0b
Manufactures and sells pharmaceutical products in South Korea.
A002800
₩4,270.00
7D
2.2%
1Y
-23.8%
MindMaze Therapeutics Holding
Market Cap: CHF 35.9m
Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.
MMTX
CHF 0.23
7D
38.2%
1Y
n/a
Covalon Technologies
Market Cap: CA$61.9m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.
COV
CA$2.24
7D
0.4%
1Y
-6.7%
Navamedic
Market Cap: NOK 392.1m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 16.35
7D
-0.3%
1Y
-35.1%
Decibel Cannabis
Market Cap: CA$57.7m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.10
7D
-9.1%
1Y
17.6%
Botanix Pharmaceuticals
Market Cap: AU$57.4m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.021
7D
0%
1Y
-86.0%
SkinBioTherapeutics
Market Cap: UK£29.8m
A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.
SBTX
UK£0.12
7D
-4.2%
1Y
-31.3%
Sprint Bioscience
Market Cap: SEK 382.0m
A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.
SPRINT
SEK 3.62
7D
-2.7%
1Y
503.3%
PDS Biotechnology
Market Cap: US$39.9m
A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.
PDSB
US$0.71
7D
3.4%
1Y
-36.8%
WDB coco
Market Cap: JP¥6.3b
Provides contract and human resource services to pharmaceutical companies in Japan.
7079
JP¥2,584.00
7D
-1.0%
1Y
-13.5%
Planet 13 Holdings
Market Cap: CA$55.3m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.17
7D
0%
1Y
-46.8%
Dyadic International
Market Cap: US$38.6m
A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.
DYAI
US$1.06
7D
0%
1Y
8.1%
Rhone Ma Holdings Berhad
Market Cap: RM 154.2m
An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.
RHONEMA
RM 0.69
7D
0%
1Y
9.4%
RP Bio
Market Cap: ₩52.4b
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
A314140
₩6,190.00
7D
10.5%
1Y
5.8%
Radiopharm Theranostics
Market Cap: AU$51.1m
A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
RAD
AU$0.013
7D
-13.3%
1Y
-45.8%
Beit Jala Pharmaceutical
Market Cap: د.أ25.3m
Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.
BJP
د.أ3.62
7D
0%
1Y
n/a
P&K Skin Research Center
Market Cap: ₩50.3b
Engages in the evaluation and research of dermatological products in South Korea.
A347740
₩1,769.00
7D
4.2%
1Y
-40.7%
Prince Pharmaceutical
Market Cap: NT$1.1b
Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.
6935
NT$31.10
7D
4.9%
1Y
25.9%
Medical Developments International
Market Cap: AU$48.4m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.46
7D
2.2%
1Y
-28.7%
Grace Therapeutics
Market Cap: US$33.8m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$2.08
7D
-7.6%
1Y
-29.8%
Infinium Pharmachem
Market Cap: ₹3.1b
Engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally.
INFINIUM
₹206.95
7D
0.4%
1Y
-19.2%
Vidipha Central Pharmaceutical
Market Cap: ₫828.1b
Produces and sells pharmaceutical products in Vietnam.
VDP
₫39,000.00
7D
-2.5%
1Y
6.8%
GeneBioTech Ltd
Market Cap: ₩42.1b
Engages in the manufacture and sale of feed additives and functional food in South Korea.
A086060
₩4,790.00
7D
-5.3%
1Y
13.5%